ArticleInfectious diseases and therapy2021

Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure.

Yuichiro Shindo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.